NPCE logo

NEUROPACE INC

NPCENASDAQ
🏆 #2950 by market capEarnings Nov 10US Equity
$13.03▲ $0.09 (+0.70%)
Pre-market · at close
🔔
Track NPCE
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.7%
7d▲ 0.9%
14d▲ 6.4%
30d▼ 5.3%
ytd▼ 15.7%
1y▲ 32.3%
🏦Market Cap
$447M
Small Cap
📈Revenue Growth (YoY)
25.1%
High Growth
📊Gross Margin
79.6%
High
💵FCF Margin
-11.8%
Thin
⚖️P/S Ratio
4.5x
Fair
Otter Score
64
Fair

Trading Snapshot

Day Range
$12.95 – $13.36
52-Week Range
$9.22 – $19.60
Volume (shares)
10,937
Avg Volume (shares)
—
Shares Outstanding
34.3M
Next Earnings
2026-11-10

Fundamentals Snapshot

Annual Revenue
$100M
Last Q Revenue
$23M
P/E Ratio
-22.8
P/S Ratio
4.5x
EPS (TTM)
$-0.56
Dividend Yield
0.00%
Dilution (1yr)
+9.4%
NPCE logo

NEUROPACE INC

NPCE
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$100M▲ +25.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
77.2%▲ +4.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$16M▼ −24.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$11M▼ −37.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
32.7M▲ +9.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$49M▲ +$11M YoY
StockOtter · stockotter.space

About NEUROPACE INC

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
64/100

Analyst Ratings

ⓘ
Consensus
Buy
16 analysts
Strong Buy4
Buy11
Hold1
Sell0
Strong Sell0
Ratings as of Oct 2026

Latest News & Updates

News unavailable.